Spectral Imaging of Melanoma Cell Adhesion & Metastasis
黑色素瘤细胞粘附的光谱成像
基本信息
- 批准号:7034472
- 负责人:
- 金额:$ 32.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The prognosis for patients with melanoma is directly related to the depth of invasion of the primary lesion at the time of diagnosis. Thus, when diagnosed at an early stage, the patient is often cured by a wide and deep excision of the melanoma. However, once primary melanoma metastasizes to different sites, the prognosis is grave because metastatic melanoma is refractory to conventional therapy. Based upon the finding that compared to melanoma precursor lesions, primary and metastatic human melanomas, and cell lines established from advanced-stage human melanoma specimens, express high levels of the cell adhesion molecules N-cadherin, M-CAM, and beta3 integrin, we postulate that these three genes/proteins, alone or in concert, play important roles in melanoma cell invasion and formation of metastases. To test this hypothesis, we propose to combine antisense gene targeting and optical bioimaging to determine, in vivo, whether these three adhesion molecules govern melanoma cell adhesion, invasion, and metastasis formation. To obtain an answer for this important but unanswered question, primary human melanomas, grown as subcutaneous tumors in nude mice, will be injected, alone and in combination, with vector constructs generating N-cadherin, M-CAM, and/or beta3 integrin antisense transcripts under the control of the human tyrosinase promoter, which is only expressed in human melanoma cells. The tumors will then be injected with different cyanine fluorochrome-conjugated antibodies specific for human N-cadherin, M-CAM, beta3 integrin, and the S100 human melanoma cell surface antigen. Thereupon, non-invasive, macroscopic Spectral Imaging will be performed to document, in vivo, possible loss of cell-cell and cell-stroma interactions in the antisense-targeted melanomas, none of which should be observed in non-targeted control tumors. Following the in vivo imaging analyses of the melanomas, the animals will be sacrificed and tissue sections of their resected tumors and different organs of the nude mice will be subjected to qualitative and quantitative microscopic Spectral Imaging. These ex vivo optical imaging analyses are expected to substantiate the dynamic intratumoral changes captured in vivo, and to provide important information regarding absence versus presence of melanoma metastases in the lungs, abdomen, and brain of mice that carded the antisense-targeted tumors compared to mice that carded the non-targeted tumors.
描述(由申请人提供):黑色素瘤患者的预后与诊断时原发病灶的浸润深度直接相关。因此,当在早期诊断时,患者通常通过广泛而深入地切除黑色素瘤而治愈。然而,一旦原发性黑色素瘤转移到不同的部位,预后是严重的,因为转移性黑色素瘤是难治性的常规治疗。与黑色素瘤前体病变相比,原发性和转移性人黑色素瘤以及从晚期人黑色素瘤标本建立的细胞系表达高水平的细胞粘附分子N-cadherin、M-CAM和β 3整联蛋白,基于这一发现,我们假设这三种基因/蛋白单独或协同在黑色素瘤细胞侵袭和转移形成中发挥重要作用。为了验证这一假设,我们建议结合联合收割机反义基因靶向和光学生物成像,以确定,在体内,这三个粘附分子是否支配黑色素瘤细胞的粘附,侵袭和转移的形成。 为了获得这一重要但未回答的问题的答案,将在裸鼠中作为皮下肿瘤生长的原发性人黑素瘤单独和组合注射在人酪氨酸酶启动子控制下产生N-钙粘蛋白、M-CAM和/或β 3整联蛋白反义转录物的载体构建体,所述人酪氨酸酶启动子仅在人黑素瘤细胞中表达。然后将对肿瘤注射不同的花青荧光染料缀合抗体,这些抗体对人N-钙粘蛋白、M-CAM、β 3整联蛋白和S100人黑素瘤细胞表面抗原具有特异性。因此,将进行非侵入性的宏观光谱成像,以在体内记录反义靶向黑色素瘤中细胞-细胞和细胞-基质相互作用的可能损失,在非靶向对照肿瘤中不应观察到任何损失。在黑色素瘤的体内成像分析后,将处死动物,并对其切除的肿瘤和裸鼠不同器官的组织切片进行定性和定量显微光谱成像。预期这些离体光学成像分析证实体内捕获的动态肿瘤内变化,并提供关于与携带非靶向肿瘤的小鼠相比,携带反义靶向肿瘤的小鼠的肺、腹部和脑中是否存在黑素瘤转移的重要信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOROTHEA BECKER其他文献
DOROTHEA BECKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOROTHEA BECKER', 18)}}的其他基金
Spectral Imaging of Melanoma Cell Adhesion & Metastasis
黑色素瘤细胞粘附的光谱成像
- 批准号:
6871262 - 财政年份:2003
- 资助金额:
$ 32.81万 - 项目类别:
Spectral Imaging of Melanoma Cell Adhesion & Metastasis
黑色素瘤细胞粘附的光谱成像
- 批准号:
6587203 - 财政年份:2003
- 资助金额:
$ 32.81万 - 项目类别:
Spectral Imaging of Melanoma Cell Adhesion & Metastasis
黑色素瘤细胞粘附的光谱成像
- 批准号:
7220598 - 财政年份:2003
- 资助金额:
$ 32.81万 - 项目类别:
Spectral Imaging of Melanoma Cell Adhesion & Metastasis
黑色素瘤细胞粘附的光谱成像
- 批准号:
6718984 - 财政年份:2003
- 资助金额:
$ 32.81万 - 项目类别:
Detection of Melanoma by Mesoscopic Spectral Imaging
通过介观光谱成像检测黑色素瘤
- 批准号:
6458377 - 财政年份:2002
- 资助金额:
$ 32.81万 - 项目类别:
Detection of Melanoma by Mesoscopic Spectral Imaging
通过介观光谱成像检测黑色素瘤
- 批准号:
6644129 - 财政年份:2002
- 资助金额:
$ 32.81万 - 项目类别:
TOMOGRAPHIC/SPECTRAL IMAGING OF FGF-MED ANGIOGENESIS
FGF-MED 血管生成的断层扫描/光谱成像
- 批准号:
6173581 - 财政年份:1999
- 资助金额:
$ 32.81万 - 项目类别:
TOMOGRAPHIC/SPECTRAL IMAGING OF FGF-MED ANGIOGENESIS
FGF-MED 血管生成的断层扫描/光谱成像
- 批准号:
6377298 - 财政年份:1999
- 资助金额:
$ 32.81万 - 项目类别:
TOMOGRAPHIC/SPECTRAL IMAGING OF FGF-MED ANGIOGENESIS
FGF-MED 血管生成的断层扫描/光谱成像
- 批准号:
6441305 - 财政年份:1999
- 资助金额:
$ 32.81万 - 项目类别:
IDENTIFICATION OF HUMAN MELANOCYTE SPECIFIC GENE(S)
人类黑素细胞特异性基因的鉴定
- 批准号:
6319794 - 财政年份:1999
- 资助金额:
$ 32.81万 - 项目类别:
相似海外基金
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056554 - 财政年份:1990
- 资助金额:
$ 32.81万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056556 - 财政年份:1989
- 资助金额:
$ 32.81万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056555 - 财政年份:1988
- 资助金额:
$ 32.81万 - 项目类别:
REPRODUCTION AND ENDOCRINE LEVELS IN THE ATHYMIC MOUSE
无胸腺小鼠的繁殖和内分泌水平
- 批准号:
3056553 - 财政年份:1987
- 资助金额:
$ 32.81万 - 项目类别:
The Athymic Mouse As a Model For the Study of Keloids
无胸腺小鼠作为瘢痕疙瘩研究的模型
- 批准号:
7816691 - 财政年份:1978
- 资助金额:
$ 32.81万 - 项目类别:
Standard Grant